Compare Core Scientific Inc (CORZ) vs Jones Lang LaSalle Inc (JLL) Price & Performance

Core Scientific (CORZ) trades at $21.18, up 8.95% in the last session, amid a technical bearish trend but strong analyst optimism. The company reported Q2 2026 revenue growth and a strategic AMD partnership for AI infrastructure, though it faces significant net losses and negative cash flow. Key support lies at $18, with resistance near $21.

The outlook is mixed: bullish analyst targets near $36 suggest upside potential from AI-driven contracts, but high cash burn and persistent losses pose risks. Investors should weigh growth prospects against financial sustainability, with sentiment hinging on execution of new deals and margin improvement.

JLL trades at $362.74, up 1.51% today and near its 52-week high, with a bullish technical signal supported by a golden cross. The company reported strong Q2 2026 earnings, beating estimates with EPS of $5.26 versus $4.56 expected, driven by leasing and capital markets growth. Revenue reached $26.12B in 2025, with net income margin improving to 3.64%. Operating cash flow surged to $1.19B in 2025, reflecting robust financial health. Analyst consensus is a Buy with a $391.50 price target, indicating potential upside from current levels.

The outlook for JLL remains positive given consistent earnings beats, revenue growth, and strong cash flow generation. Key opportunities include momentum in advisory services and recurring revenue streams. Risks involve economic sensitivity to real estate cycles and competitive pressures. Institutional interest is solid, with firms like Bank of America increasing holdings. The stock's valuation at a P/E of 17.43 appears reasonable relative to growth prospects, supporting a constructive view for investors seeking exposure to commercial real estate services.